Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: ggersh who wrote (173241)	6/16/2021 8:26:40 PM
From: TobagoJack	Respond to of 218880

'they' do not <<want us all to die>> not right away 'they' want us to pay, and then die, akin to doing a Boeing 737Max to us, now a verb, as in 737Max-ed

To: ggersh who wrote (173241)	6/17/2021 4:03:55 AM
From: sense	Read Replies (1) \| Respond to of 218880

the debatable premise that the drug’s effect on brain amyloid was likely to help patients with Alzheimer’s disease... It's not debatable... The drug... the approach the drug employs... has no potential to help, at all, and it is a known that the drug WILL inflict greater harm... exactly as it did during the trials they conducted... There is nothing at all capable of backing this approval... other than $$$ and corruption... Now, they're not even pretending that "the science" matters... That's honest, at least... since it doesn't have anything to do with it ?